Compound ID | 1280
ETX'991
Class: Cell wall synthesis inhibitor
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. PBP-3 inhibitor |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Institute where first reported: | Entasis Therapeutics |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| Reason dropped: | High porin permeation |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.